More and more bacterial pathogens are developing resistance. There is an increasing risk that common drugs will no longer be effective against infectious diseases. That is why scientists around the ...
Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a ...
More and more bacterial pathogens are developing resistance. There is an increasing risk that common drugs will no longer be effective against infectious diseases. That is why scientists around the ...
The bacterium Vibrio cholerae has a defense system against bacteriophages called CBASS. This phage defense mechanism makes the cholera pathogen sensitive to antibiotics. Bacteria have an immune system ...
Scientists at McMaster University and the Massachusetts Institute of Technology have discovered a novel antibiotic to target ...
There is a compelling need to produce new antibiotics that hamper severe opportunistic infections, especially in immunocompromised individuals, such as those caused by gram-negative Pseudomonas ...
Lakewood-Amedex Biotherapeutics Inc., a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, ...
Bacteria have an immune system that protects them against viruses known as bacteriophages. A research team from the Universities of Tübingen and Würzburg has now shown how this immune system enhances ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback